FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/06/014373 [Registered on: 01/06/2018] Trial Registered Prospectively
Last Modified On: 30/05/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Other 
Public Title of Study   To evaluate the clinical efficacy of Keel Vayu Nivarana Chooranam(Internal), Vathathirku Thylam(External) for the treatment of Uthiravatha Suronitham(Rheumatoid Arthritis) 
Scientific Title of Study   An Open Clinical Study to evaluate the efficacy of Siddha polyherbal medicine Keelvayu Nivarana Chooranam(Internal), Vathathirku Thylam(External) and Vedhu(External Therapy) for the treatment of Uthiravatha Suronitham(Rheumatoid Arthritis) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  BDurga Devi 
Designation  PG Scholar 
Affiliation  Govt Siddha Medical College Hospital 
Address  Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone    
Fax    
Email  dr.devidurga29@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Poongodigandhimathi 
Designation  Professor 
Affiliation  Govt Siddha Medical College Hospital 
Address  Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone    
Fax    
Email  arunapriya1995@gmail.com  
 
Details of Contact Person
Public Query
 
Name  BDurga Devi 
Designation  PG Scholar 
Affiliation  Govt Siddha Medical College Hospital 
Address  Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone    
Fax    
Email  dr.devidurga29@gmail.com  
 
Source of Monetary or Material Support  
BDurga Devi 
 
Primary Sponsor  
Name  BDurga Devi 
Address  Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital Tirunelveli 
Type of Sponsor  Other [PG Scholar Stipend] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
BDurga Devi  Govt Siddha Medical College Hospital Tirunelveli  Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital, Tirunelveli
Tirunelveli
TAMIL NADU 
2572736

dr.devidurga29@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Govt Siddha Medical College Palayamkottai  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients suffering from Rheumatoid arthritis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Keelvayu Nivarana Chooranam and Vathathirku Thylam  Keelvayu Nivarana Chooranam-650-1300mg-oral route twice daily and Vathathirku thylam-30ml(External) 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Symmetrical joint involvement
2. Arthritis of 3 or more joints
3. Rheumatoid factor positive
4. Morning stiffness
5. Swelling especially in the inter phalangeal joint.
6. Patients who are willing for admission and stay in IPD for 30 to 48 days or willing to attend OPD
7. Patient who is willing to undergo radiological investigation and give blood and urine samples for laboratory investigation.
8. Patient willing to sign the informed consent stating that he/she will consciously stick to the treatment during 30 to 48 days but can OPD out of the trial of his/her own conscious discretion.
 
 
ExclusionCriteria 
Details  1. Systemic illness.
2. Pregnant Women and Lactating Mother
3. History of trauma
4. Neurological disorder
5. Tubercular arthritis
6. Any other serious illness
7. Psoriatic arthritis
8. Gouty arthritis
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the clinical efficacy of “KEELVAYU NIVARANA CHOORANAM ” (internal) & “VATHATHIRKU THYLAM” (external) and External Therapy Vedhu in reducing the pain and restricted joint movements in the treatment of ‘Uthiravatha suronitham” (rheumatoid arthritis).  48 Days 
 
Secondary Outcome  
Outcome  TimePoints 
To study the effect of Vedhu (steam bath) in reducing the pain towards the efficacy of medicine.  48 Days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/07/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Study enrollment:

Patients reporting at the OPD of Govt. Siddha medical college and hospital, Palayamkottai. With the clinical symptoms  the Symmetrical joint involvement, Arthrits of 3 or more joints, morning stiffness  Swelling especially in the inter phalangeal joints, will be examined clinically for enrolling in the study based on the inclusion and exclusion criteria.

            The patients who are to be enrolled would be informed (form iv) about the study, trial drug, possible outcomes and the objectives of the study in the language and terms understandable to them.

            After ascertaining the patient’s willingness, informed consent would be obtained in writing from them in the consent form (form iv).  All these patients will be given unique registration card in which patient’s registration number of the study, address, phone number and doctor’s phone number etc., will be given, so as to report easily should any complications arise.

            complete clinical history, complaints and duration, examination findings—all would be recorded in the prescribed proforma in the history and clinical assessment forms separately.  Screening form – i will be filled up.   Form – ii and form – iii will be used for recording the patient’s history, clinical examination of symptoms and signs and laboratory investigations respectively.  Patients would be advised to take the trial drug and appropriate dietary advice (form iv-d) would be given according to the patient’s perfect understanding.

Conduct of the study:

            15ml of Vellai ennai is given in early morning, on the very first day of treatment for purgation. This will help to bring the vitiated mukkutram back to normal. From the next day, the trial drug is given for treatment.

Then the trial drug KEELVAYU NIVARANA CHOORANAM (internal), VATHATHIRKU THYLAM (external) is given continuously for 30 to 48 days. OP patients should visit the hospital once in seven days.  At each clinical visit clinical assessment is done and prognosis is noted.  For IP patients the drug is given for 40 days and the clinical assessment is done daily. patients will be given Vedhu (steam bath) treatment along with their internal medicine. The results will be compared at the end of the study. Laboratory investigations & radiological investigation are done 0 day, 20th day, 40th day of the trial. For IP patients, who are not in a situation to stay in the hospital for a long time is advised to attend the OPD for further follow-up. After the end of the treatment, the patient is advised to visit the OPD for another 2 months for follow-up. If any trial patient who fails to collect the trial drug on the prescribed day but wants to continue in the trial from the next day , he/she will be allowed, but defaulters of one week and more will not be allowed to continue and be withdrawn from the study with a fresh case being included.

 

Data management:

            After enrolling the patient for the study, a separate file for each patient will be opened and all forms will be kept in the file.  Study No. and patient identity No. will be written on the top of file for easy identification.  Whenever study patient visits OPD during the study period, the respective patient file will be taken and necessary entries will be made at the assessment form or other suitable form.  The screening forms will be filed separately.  The data recordings will be monitored by HOD and pharmaco-vigilance committee.  All forms will be further scrutinized in presence of investigators with concerned department faculties for logical errors and incompleteness of data to avoid any bias.  No modification in the results is permitted for unbiased report.


 
Close